UBE2T and hepatocellular carcinoma: Moreover, further studies have revealed that inhibiting UBE2T expression downregulates cyclin B1 and cyclin-dependent kinase 1 (CDK1) levels, leading to G2/M cell cycle arrest and the inhibition of HCC cell proliferation [85].